What Is Wegovy?

Wegovy (semaglutide 2.4mg) is a once-weekly injectable medication manufactured by Novo Nordisk, the same company behind Ozempic. While Ozempic was developed for type 2 diabetes, Wegovy was designed from the ground up as a weight management drug.

The active ingredient in both is identical — semaglutide, a GLP-1 receptor agonist. The difference is the dose: Wegovy goes up to 2.4mg per week, while Ozempic maxes out at 2mg. That extra dose translates to meaningfully more weight loss in clinical trials.

Wegovy was approved by the US FDA in June 2021, the European Medicines Agency in January 2022, and has been registered by SAHPRA (South African Health Products Regulatory Authority) for use in South Africa.

How Wegovy Works

Semaglutide mimics a naturally occurring hormone called GLP-1 (glucagon-like peptide-1), which plays multiple roles in metabolism:

• Appetite suppression: GLP-1 acts on the hypothalamus — the brain's hunger centre — to reduce appetite and cravings. Most patients report feeling satisfied with smaller portions and experiencing fewer food obsessions
• Delayed gastric emptying: Food stays in the stomach longer, keeping you feeling full for hours after eating
• Improved insulin sensitivity: Better blood sugar regulation reduces insulin spikes that drive fat storage, particularly around the abdomen
• Reduced reward response to food: Emerging research suggests semaglutide dampens the brain's dopamine response to highly palatable foods, reducing the "pull" of junk food

Wegovy vs Ozempic: What South Africans Need to Know

This is the question most South Africans ask first. Both contain semaglutide. Both are weekly injections from Novo Nordisk. But there are important differences.

For a detailed head-to-head comparison including clinical trial data, read our full guide: Wegovy vs Ozempic in South Africa.

Wegovy Dose Escalation Schedule

Wegovy uses a gradual 5-step dose escalation to minimise gastrointestinal side effects. Rushing the escalation increases nausea, vomiting, and the likelihood of discontinuation. Your doctor will typically follow this schedule:

Who Qualifies for Wegovy in South Africa?

Wegovy is not available over the counter. You need a prescription from a registered South African doctor. The standard prescribing criteria are:

• BMI of 30 or higher (obesity) — regardless of comorbidities
• BMI of 27 or higher with at least one weight-related condition: type 2 diabetes, hypertension, high cholesterol (dyslipidaemia), obstructive sleep apnoea, or cardiovascular disease
• Age 18+ (Wegovy is approved for adolescents 12+ in some countries, but SA prescribing typically follows adult guidelines)

Who should NOT take Wegovy

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Pregnant or planning pregnancy (stop Wegovy at least 2 months before conception)
• History of pancreatitis (use with extreme caution)
• Severe kidney disease or gastroparesis
• Currently taking other GLP-1 receptor agonists or insulin (without medical coordination)

Cost of Wegovy in South Africa (2026)

Cost is the biggest barrier for most South Africans. Wegovy is not cheap, and medical aid coverage remains limited.

First-year total: Expect to spend approximately R60,000 – R75,000 on Wegovy in the first year, including the escalation phase. This works out to roughly R5,000 – R6,250 per month on average.

Medical Aid Coverage

The situation with medical aid coverage for Wegovy in South Africa is evolving but still restrictive:

• Discovery Health: Some higher-tier plans may cover a portion if prescribed for obesity with documented comorbidities and a motivation letter from an endocrinologist. The Chronic Illness Benefit does not typically extend to weight management drugs
• Bonitas: BonComplete and BonClassic plans have provided partial cover in some cases. Check with your scheme administrator
• Momentum Health: Limited cover on premium plans. Requires pre-authorisation and specialist motivation
• Government sector: Not available through public hospitals or community health centres

Wegovy Side Effects

Wegovy shares the same side-effect profile as Ozempic because the active ingredient is identical. However, the higher dose means side effects can be more pronounced, particularly during escalation.

Common side effects (affecting 10%+ of users)

• Nausea — the most common side effect, particularly in the first 8 weeks. Usually improves as your body adjusts. Eating smaller meals, avoiding greasy food, and staying hydrated helps
• Diarrhoea — often intermittent and linked to dietary choices. High-fat meals tend to trigger it
• Constipation — equally common. Increase fibre intake gradually and drink at least 2 litres of water daily
• Vomiting — more common at dose escalation points. If persistent, your doctor may slow the escalation
• Headache — typically mild and resolves within the first month
• Fatigue — partly from reduced calorie intake. Ensure adequate protein (1.2-1.6g per kg body weight)

Serious side effects (seek medical attention)

• Pancreatitis: Severe, persistent abdominal pain radiating to the back. Rare but serious. Stop medication and seek emergency care
• Gallbladder problems: Rapid weight loss increases gallstone risk. Report upper-right abdominal pain or jaundice
• Kidney injury: Dehydration from vomiting or diarrhoea can stress the kidneys. Maintain hydration
• Allergic reactions: Swelling of face, lips, tongue. Very rare but requires immediate medical attention
• Thyroid tumours: Semaglutide caused thyroid C-cell tumours in rodent studies. The relevance to humans is unclear, but Wegovy is contraindicated in patients with MTC family history

For a comprehensive breakdown including long-term data, see our semaglutide side effects guide.

Wegovy Availability in South Africa

Availability has been the biggest frustration for South African patients. Global demand for semaglutide has outstripped Novo Nordisk's manufacturing capacity, and South Africa — as a smaller market — has experienced periodic shortages.

Where to get Wegovy in SA

• Major pharmacy chains: Dis-Chem and Clicks stock Wegovy when available. Call ahead to confirm stock before visiting
• Independent pharmacies: Some independent pharmacies in Gauteng, Western Cape, and KZN have been more reliable at maintaining stock through direct Novo Nordisk supply agreements
• Hospital pharmacies: Netcare and Mediclinic hospital pharmacies may have stock when retail pharmacies do not
• Online pharmacies: SAHPRA-registered online pharmacies like MedPak and ZipHealth can deliver to your door with a valid prescription

What to do when Wegovy is out of stock

• Ozempic as alternative: Your doctor can prescribe Ozempic at 1mg or 2mg as a substitute. The dose is lower but the mechanism is identical
• Compounded semaglutide: Some SA compounding pharmacies produce semaglutide. Quality control varies — only use SAHPRA-compliant compounders. Read our compounded semaglutide guide
• Tirzepatide (Mounjaro): A dual GIP/GLP-1 agonist that may produce even greater weight loss. Increasingly available in SA. See our Mounjaro guide

Diet and Lifestyle on Wegovy

Wegovy is not a magic injection. Without dietary changes and exercise, results will be modest and weight regain after stopping is almost certain. Think of Wegovy as a tool that makes healthy eating dramatically easier — you still need to choose the right foods.

What to eat on Wegovy

• Prioritise protein: Aim for 1.2-1.6g per kg body weight daily. Good SA sources: chicken breast, eggs, biltong (watch the salt), tinned tuna, cottage cheese, lentils, and Greek yoghurt. Protein protects against muscle loss — a real risk with rapid weight loss
• Eat vegetables at every meal: Spinach, butternut, broccoli, gem squash, cabbage, and tomatoes. Volume without excessive calories
• Choose complex carbs: Sweet potato, brown rice, oats, and wholewheat bread rather than white bread, white rice, and refined pasta
• Healthy fats in moderation: Avocado, nuts, olive oil. These keep meals satisfying without overwhelming the slowed digestive system
• Stay hydrated: At least 2 litres of water daily. Rooibos tea is an excellent caffeine-free option that counts toward your fluid intake

Foods to avoid or limit

• High-fat fried foods: Semaglutide slows gastric emptying, making greasy foods sit heavily and worsen nausea. Avoid vetkoek, deep-fried chips, and heavy curries initially
• Sugary drinks: Cooldrinks, fruit juices, and sweetened coffee add empty calories and spike blood sugar
• Alcohol: Semaglutide can reduce alcohol tolerance dramatically. Many patients report feeling drunk much faster. Read our full guide on Ozempic/Wegovy and alcohol
• Large portions: Your stomach empties slower on Wegovy. Eating too much at once causes severe nausea and discomfort. Eat until 70% full

For a structured eating plan, see our semaglutide diet plan for South Africa and foods to avoid on semaglutide.

Exercise recommendations

Exercise is non-negotiable on Wegovy — not primarily for calorie burning, but to preserve muscle mass. Rapid weight loss without resistance training means you lose muscle alongside fat, which tanks your metabolism and leaves you weaker.

• Resistance training: 2-3 sessions per week. Squats, lunges, push-ups, rows. You do not need a gym — bodyweight exercises at home work. Our guide on exercise on semaglutide has a full programme
• Walking: 7,000-10,000 steps daily. Free, accessible, and excellent for metabolic health. South Africa's climate makes outdoor walking feasible year-round in most provinces
• Flexibility: Yoga or stretching 2x per week to maintain joint health, particularly if you are over 40

What Results to Expect

The landmark STEP clinical trial programme (involving over 15,000 participants) showed consistent results for Wegovy:

• STEP 1: Adults with obesity (no diabetes) lost an average of 14.9% body weight over 68 weeks versus 2.4% with placebo
• STEP 2: Adults with type 2 diabetes lost 9.6% body weight (diabetes reduces semaglutide's weight-loss effect)
• STEP 3: Combined with intensive behavioural therapy, participants lost 16% body weight
• STEP 4: Patients who stopped Wegovy regained approximately two-thirds of their lost weight within a year

Weight loss timeline

For a more detailed month-by-month breakdown, see our semaglutide weight loss timeline.

What Happens When You Stop Wegovy?

This is the critical question most patients do not ask until it is too late. The STEP 4 trial data is clear: stopping semaglutide leads to significant weight regain.

• Within 1 year of stopping, patients regained approximately 67% of the weight they had lost
• Appetite returns to pre-treatment levels within 2-4 weeks of stopping
• Metabolic improvements (blood sugar, cholesterol, blood pressure) also partially reverse

This does not mean Wegovy is pointless — it means you should plan for the long term. Options include:

1. Indefinite use: Many experts now view obesity medications like long-term blood pressure medication — you take them as long as they are needed
2. Dose reduction: Some doctors taper patients to a lower maintenance dose (e.g., 1mg weekly) after reaching goal weight
3. Lifestyle lock-in: Use the appetite suppression window to build permanent habits — meal prep routines, exercise habits, relationship with food — that persist after stopping

Read our full article: Weight regain after stopping semaglutide.

Wegovy for Specific Groups

Women in menopause

Menopausal women face unique challenges with semaglutide — from bone density concerns to HRT interactions. Wegovy can be effective but requires careful monitoring. Read our dedicated guide: Ozempic and menopause in South Africa.

Women with PCOS

Polycystic ovary syndrome drives insulin resistance and weight gain. Semaglutide can help with both, and may improve fertility in some cases. See: Ozempic for PCOS in South Africa.

People with type 2 diabetes

If you have type 2 diabetes, your doctor may prefer Ozempic (specifically approved for diabetes) or may use Wegovy if weight management is the primary goal. Blood sugar monitoring is essential. Read: Ozempic and diabetes in South Africa.

Adults over 50

Muscle preservation becomes critical. Higher protein intake and mandatory resistance training are essential for older adults on semaglutide. See: Weight loss after 50 in South Africa.

Frequently Asked Questions

Is Wegovy available in South Africa?

Yes, Wegovy has been registered by SAHPRA. However, availability has been inconsistent due to global supply constraints from Novo Nordisk. Many pharmacies experience stock shortages. Check Dis-Chem, Clicks, or independent pharmacies, and ask your doctor about Ozempic as an alternative when Wegovy is unavailable.

How much does Wegovy cost per month in South Africa?

Approximately R4,500 to R6,500 per month, depending on the dose tier. The maintenance dose (2.4mg) is at the higher end. Most medical aids do not cover Wegovy for weight loss, though some premium plans may provide partial cover with a specialist motivation letter.

Can my GP prescribe Wegovy or do I need a specialist?

Any registered South African doctor (GP or specialist) can prescribe Wegovy. However, a motivation letter from an endocrinologist or bariatric physician carries more weight with medical aid schemes if you are seeking cover. GPs are more likely to prescribe Ozempic off-label than Wegovy due to familiarity.

How long do I need to take Wegovy?

There is no fixed duration. Clinical data shows that stopping semaglutide leads to weight regain in the majority of patients. Many doctors now recommend long-term or indefinite use, similar to blood pressure or cholesterol medication. Discuss a personalised plan with your prescribing doctor.

Can I switch between Wegovy and Ozempic?

Yes. Because both contain semaglutide, switching is straightforward. Your doctor will match the dose as closely as possible. The most common switch is from Ozempic 1mg to Wegovy 1.7mg or 2.4mg when a higher dose is needed for weight loss. No washout period is required.

Is Wegovy safe long-term?

Semaglutide has been studied for up to 2 years in the STEP trials with a favourable safety profile. The SELECT cardiovascular outcomes trial (2023) showed semaglutide reduced the risk of major cardiovascular events by 20% in overweight adults. Long-term data beyond 5 years is still limited, as with any relatively new medication class. Regular medical check-ups are recommended while on treatment.

What is the difference between Wegovy and Mounjaro?

Wegovy contains semaglutide (a GLP-1 agonist). Mounjaro contains tirzepatide (a dual GIP/GLP-1 agonist) which targets two hormonal pathways instead of one. Clinical trials suggest Mounjaro may produce greater weight loss (up to 22% body weight) but it is newer and availability in South Africa is still building. See our Mounjaro guide and medication comparison for full details.

Related Guides